Debate erupts over new drug pricing policy

It is fair that the Korean government should consider the new drug pricing issue under the current pharmaceutical circumstances, the nation's pharmaceutical group asserted on June 20.

The Korea Pharmaceutical Manufacturers Association (KPMA) said on July 20 that it had submitted its written opinion to the National Assembly, requesting the government to consider the implementation of a positi...